Literature DB >> 17261499

Two cases of secondary acute myeloid leukemia accompanying adult T-cell leukemia/lymphoma.

Satsuki Owatari1, Maki Otsuka, Kimiharu Uozumi, Taketsugu Takeshita, Shuichi Hanada.   

Abstract

We identified 2 cases of secondary acute myeloid leukemia (AML) following adult T-cell leukemia/lymphoma (ATL) in patients who had previously received chemotherapy. Both cases were thought to represent therapy-related AML because the patients had previously received combination chemotherapy including epipodophyllotoxin, anthracycline, and alkylating agents for the ATL. The cases were diagnosed as AML M4 with eosinophilia and AML M2, with the chromosomal abnormalities inv(16)(p13q22) and t(8;21)(q22;q22), respectively. In our hospital, only these 2 cases of secondary AML accompanying ATL were identified among 90 cases of acute- or lymphoma-type ATL diagnosed from October 1999 to July 2006. The frequency of coexisting AML and ATL is lower than that reported for acute leukemia coexisting with other lymphoid malignancies. The low frequency of secondary leukemia with ATL may be associated with the short survival times of ATL patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17261499     DOI: 10.1532/IJH97.06145

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  22 in total

1.  Major prognostic factors of patients with adult T-cell leukemia-lymphoma: a cooperative study. Lymphoma Study Group (1984-1987).

Authors: 
Journal:  Leuk Res       Date:  1991       Impact factor: 3.156

Review 2.  Possible pathogenetic significance of specific chromosome abnormalities and activated proto-oncogenes in malignant diseases of man.

Authors:  J Pedersen-Bjergaard; P Andersson; P Philip
Journal:  Scand J Haematol       Date:  1986-02

Review 3.  Possible association between adult T-cell leukemia/lymphoma and acute myeloid leukemia.

Authors:  K Tsukasaki; T Koba; M Iwanaga; K Murata; T Maeda; S Atogami; H Nakamura; Y Yamada; S Kamihira; M Tomonaga
Journal:  Cancer       Date:  1998-02-01       Impact factor: 6.860

4.  A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303.

Authors:  Y Yamada; M Tomonaga; H Fukuda; S Hanada; A Utsunomiya; M Tara; M Sano; S Ikeda; K Takatsuki; M Kozuru; K Araki; F Kawano; M Niimi; K Tobinai; T Hotta; M Shimoyama
Journal:  Br J Haematol       Date:  2001-05       Impact factor: 6.998

5.  Cytogenetic and clinical investigations in 76 cases with therapy-related leukemia and myelodysplastic syndrome.

Authors:  A Iurlo; C Mecucci; A Van Orshoven; J L Michaux; M Boogaerts; L Noens; A Bosly; A Louwagie; H Van Den Berghe
Journal:  Cancer Genet Cytogenet       Date:  1989-12

6.  Favorable cytogenetic abnormalities in secondary leukemia.

Authors:  P Fenaux; D Lucidarme; J L Laï; F Bauters
Journal:  Cancer       Date:  1989-06-15       Impact factor: 6.860

7.  Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavage.

Authors:  W Ross; T Rowe; B Glisson; J Yalowich; L Liu
Journal:  Cancer Res       Date:  1984-12       Impact factor: 12.701

8.  Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia.

Authors:  C H Pui; R C Ribeiro; M L Hancock; G K Rivera; W E Evans; S C Raimondi; D R Head; F G Behm; M H Mahmoud; J T Sandlund
Journal:  N Engl J Med       Date:  1991-12-12       Impact factor: 91.245

Review 9.  Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure.

Authors:  E G Levine; C D Bloomfield
Journal:  Semin Oncol       Date:  1992-02       Impact factor: 4.929

10.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

View more
  3 in total

1.  Acute myeloid leukemia with the t(8;21) translocation: clinical consequences and biological implications.

Authors:  Håkon Reikvam; Kimberley Joanne Hatfield; Astrid Olsnes Kittang; Randi Hovland; Øystein Bruserud
Journal:  J Biomed Biotechnol       Date:  2011-05-03

2.  Therapy-related Acute Myeloid Leukemia after the Long-term Administration of Low-dose Etoposide for Chronic-type Adult T-cell Leukemia-lymphoma: A Case Report and Literature Review.

Authors:  Naoki Shimada; Nobuhiro Ohno; Ryuji Tanosaki; Shigeo Fuji; Yuhko Suzuki; Koichiro Yuji; Kaoru Uchimaru; Arinobu Tojo
Journal:  Intern Med       Date:  2017-07-15       Impact factor: 1.271

3.  An Unusually Short Latent Period of Therapy-Related Myeloid Neoplasm Harboring a Rare MLL-EP300 Rearrangement: Case Report and Literature Review.

Authors:  Reina Takeda; Kazuaki Yokoyama; Seiichiro Kobayashi; Toyotaka Kawamata; Sousuke Nakamura; Tomofusa Fukuyama; Mika Ito; Nozomi Yusa; Eigo Shimizu; Nobuhiro Ohno; Rui Yamaguchi; Seiya Imoto; Satoru Miyano; Kaoru Uchimaru; Arinobu Tojo
Journal:  Case Rep Hematol       Date:  2019-10-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.